Citius Pharmaceuticals (CTXR) vs Tempest Therapeutics (TPST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Citius Pharmaceuticals (CTXR) has outperformed Tempest Therapeutics (TPST) over the past year, losing 64.2% versus a loss of 92.6%. Over five years, CTXR leads with a -99.0% price change compared with -99.6% for TPST. Citius Pharmaceuticals is the larger company by market cap ($13.8 million vs $13.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTXR | TPST |
|---|---|---|
| Share price | $0.5011 | $0.7914 |
| Market cap | $13.76M | $13.37M |
| 1-day change | +4.24% | +0.50% |
| YTD return | -35.51% | -72.43% |
| 1-year return | -64.21% | -92.63% |
| 5-year return | -99.04% | -99.59% |
| EPS (TTM) | $-1.75 | $-3.98 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.19 | $12.23 |
| 52-week low | $0.469 | $0.743 |
| Distance from 52-week high | -77.12% | -93.53% |
| Average volume | 534.62K | 2.63M |
| Shares outstanding | 27.45M | 16.89M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CTXR has outperformed TPST by 28.4 percentage points over the past year.
CTXR vs TPST FAQ
Which is bigger, Citius Pharmaceuticals or Tempest Therapeutics?
Citius Pharmaceuticals (CTXR) is larger, with a market capitalization of $13.76M compared with $13.37M for Tempest Therapeutics (TPST).
Which stock has performed better over the past year, CTXR or TPST?
CTXR returned -64.21% over the past 12 months, compared with -92.63% for TPST (price return, excluding dividends). Past performance does not predict future results.
Are Citius Pharmaceuticals and Tempest Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.